(Total Views: 753)
Posted On: 04/03/2018 11:53:51 AM
Post# of 17915
$DTHR Key Accomplishments in 2017
Completed a proof-of-concept study for lead product, ReminX, at University of California San Diego. Study results in 14 patients suffering from dementia showed significant reductions in anxiety, depression, and overall emotional distress.
Completed a successful beta test of Dthera's proprietary sales funnel, providing key proof points in support of achieving 2018 sales targets for ReminX.
In September, the Company commenced trading on the OTCQB® Venture Market.
https://finance.yahoo.com/news/uipath-set-hos...00309.html
Completed a proof-of-concept study for lead product, ReminX, at University of California San Diego. Study results in 14 patients suffering from dementia showed significant reductions in anxiety, depression, and overall emotional distress.
Completed a successful beta test of Dthera's proprietary sales funnel, providing key proof points in support of achieving 2018 sales targets for ReminX.
In September, the Company commenced trading on the OTCQB® Venture Market.
https://finance.yahoo.com/news/uipath-set-hos...00309.html
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
